Analyst
Mizuho Capital Markets
Equibles does not estimate personal net worth.
Evan Singerman is recorded as Analyst at Mizuho Capital Markets. Evan Singerman has spoken on 1 earnings call across 1 company, most recently for Gilead Sciences, Inc. on August 7, 2025. The companies whose calls Evan Singerman spoke on are classified in the Healthcare sector.
“Given the importance of the Yes2Go launch and the recent changes to the HHS Preventative Task Force, if PrEP is removed as a preventative medicine broadly, how does this change your approach to commercialization, and is there a potential also impact to COVID?”
Mizuho Capital Markets
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
